Published in World J Gastroenterol on January 14, 2017
Signatures of mutational processes in human cancer. Nature (2013) 21.63
Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer (1988) 7.05
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet (2009) 5.29
Inhibition of hepatitis B virus replication by APOBEC3G. Science (2004) 5.15
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet (2013) 4.69
Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet (2013) 3.94
Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science (1993) 3.52
Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet (2003) 3.11
Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol (2009) 2.95
Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci U S A (2005) 2.68
Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol (2005) 2.54
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol (2009) 2.11
APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep (2011) 2.07
APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol (2004) 1.97
A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet (2011) 1.96
G to A hypermutation of hepatitis B virus. Hepatology (2005) 1.83
APOBEC-mediated interference with hepadnavirus production. Hepatology (2005) 1.82
Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J Virol (2007) 1.52
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog (2010) 1.43
Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS One (2009) 1.39
Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection. J Virol (1991) 1.35
Medical virology of hepatitis B: how it began and where we are now. Virol J (2013) 1.34
Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J Gen Virol (2008) 1.25
Hepatitis B virus resistance to antiviral drugs: where are we going? Liver Int (2011) 1.21
Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma. Hepatology (2007) 1.18
The role of cytidine deaminases on innate immune responses against human viral infections. Biomed Res Int (2013) 1.11
APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians. AIDS (2006) 1.00
Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma. Cancer Lett (2013) 0.88
Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in children. J Acquir Immune Defic Syndr (2013) 0.87
The inhibition of hepatitis B virus by APOBEC cytidine deaminases. J Viral Hepat (2013) 0.87
Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population. J Viral Hepat (2012) 0.85
Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B. J Viral Hepat (2013) 0.82